Related Experiment Video
Updated: Aug 13, 2026
Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice
Published on: April 15, 2014
Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis
1Department of Cell Biology, University of Alabama at Birmingham 35294-0005, USA.
Abstract:
One of the characteristic features of microglia is their rapid activation in response to injury, inflammation, neurodegeneration, infection, and brain tumors. This review focuses on the role of the microglia in multiple sclerosis (MS), a chronic inflammatory demyelinating disease of the central nervous system (CNS), and in the animal model of MS, experimental allergic encephalomyelitis (EAE). Microglial activation in MS and EAE is thought to contribute directly to CNS damage through several mechanisms, including production of proinflammatory cytokines, matrix metalloproteinases, and free radicals. In addition, activated microglia serve as the major antigen-presenting cell in the CNS, likely contributing to aberrant immune reactivity at this site. A mechanistic understanding of the way in which microglia are activated and ultimately inhibited is crucial for the formulation of therapeutic modalities to treat MS and other CNS autoimmune disease.
Insights
Microglia rapidly activate in response to CNS damage, contributing to multiple sclerosis (MS) pathology. Understanding microglial activation is key to developing therapies for MS and other autoimmune diseases.
Area of Science:
- Neuroimmunology
- Central Nervous System (CNS) Inflammation
Background:
- Microglia are the primary immune cells of the CNS.
- Microglial activation is a hallmark of neurological conditions including injury, inflammation, neurodegeneration, infection, and brain tumors.
Purpose of the Study:
- This review examines the role of microglia in multiple sclerosis (MS).
- It also explores the function of microglia in experimental allergic encephalomyelitis (EAE), the primary animal model for MS.
Main Methods:
- This review synthesizes existing literature on microglial function in MS and EAE.
- Focus is placed on the mechanisms of microglial activation and their contribution to CNS damage.
Main Results:
- Activated microglia contribute to CNS damage in MS and EAE via proinflammatory cytokines, matrix metalloproteinases, and free radicals.
- Activated microglia function as antigen-presenting cells in the CNS, potentially driving aberrant immune responses.
Conclusions:
- Understanding microglial activation mechanisms is crucial for developing therapeutic strategies.
- Targeting microglial pathways may offer new treatments for MS and other CNS autoimmune diseases.
